Echo Therapeutics, Inc. Appoints Alan W. Schoenbart as Chief Executive Officer
March 22, 2017 at 06:10 am EDT
On March 21, 2017, Alan W. Schoenbart, currently the Echo Therapeutics, Inc.’s Interim Chief Executive Officer and Chief Financial Officer, was appointed by the board of directors of the company to serve as Chief Executive Officer of the company. He will also continue as Chief Financial Officer. Mr. Schoenbart was also appointed by the Board as a director to serve in Class I to fill a vacancy on the Board.